Little evidence supports autism treatment options in adolescents

There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism.

National type I diabetes prevention trial now an option for younger children

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.

Doctors see rise in tick-borne illnesses and other insect-related infections

MRSA in pregnancy may be less dangerous than previously thought

Vanderbilt pediatric infectious disease researchers studying antibiotic-resistant staph say fears that mothers carrying the germ may set their newborns up for infection are unfounded.

Plant compound quells inflammation

Berberine, an herbal remedy for diarrhea and intestinal parasites, may be an effective treatment for gastrointestinal inflammatory diseases.

Studies shed new light on how nitric oxide is produced

The discovery of a previously unrecognized and pivotal role of enzyme ASL in nitric oxide production could potentially lead to new therapies for babies with pulmonary hypertension.